Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Role of Central Sensitization in Short-Term Clinical Outcomes in Chronic Nonspecific Low Back Pain

NCT07826546 is registered in ClinicalTrials.gov with Mardin Artuklu University as lead sponsor.

NCT NCT07826546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07826546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Role of Central Sensitization in Short-Term Clinical Outcomes in Chronic Nonspecific Low Back Pain
Lead sponsor
Mardin Artuklu University
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2026
Completion date
June 1, 2027
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic nonspecific low back pain